William T. Andrews - Nov 20, 2025 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Medical Officer
Signature
/s/ William T. Andrews
Stock symbol
CPRX
Transactions as of
Nov 20, 2025
Transactions value $
$0
Form type
4
Date filed
11/24/2025, 08:08 PM
Previous filing
Jun 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Andrews William T. Chief Medical Officer 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES /s/ William T. Andrews 2025-11-24 0001638459

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +98.7K +70.61% $0.00 238K Nov 20, 2025 Common Stock 98.7K $22.77 Direct F1
transaction CPRX Restricted Stock Units Award $0 +29.8K +12.49% $0.00 268K Nov 20, 2025 Common Stock 29.8K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027 and 1/3rd on November 20, 2028.
F2 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F3 Shares of common stock will be delivered to the Reporting Person upon vesting.